Integra LifeSciences Holdings (IART) Stock Forecast & Price Prediction

Estimation of the future price movement of Integra LifeSciences Holdings stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $40.93

Concensus $71.00

Low $50.00

Median $74.00

High $86.00

Based on analysts projections #IART is expected to experience a positive growth trajectory over the next year.

The current average IART price target, as estimated by these analysts, is $71.00.

The predictions for the future IART stock price range from a low of $50.00 to a high of $86.00, highlighting the variability of market expectations for IART.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

IART stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Matt O'Brien
Piper Sandler
October 26, 2022 Buy 50.00 46.85
Piper Sandler
July 28, 2022 Buy 55.00 56.53
Anthony Petrone
May 20, 2021 Buy 86.00 70.95
Larry Biegelsen
Wells Fargo
April 29, 2021 Buy 74.00 75.07
Shagun Singh Chadha
RBC Capital
April 29, 2021 Buy 74.00 75.07

Integra LifeSciences Holdings (IART) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Integra LifeSciences Holdings is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Strong Buy

Financial Scores

Updated on: 07/12/2023

Altman Z-Score: 2.0

Piotroski Score: 6.0

ESG Score

Updated on: 07/12/2023

Environmental: 65.4

Social: 69.6

Governance: 69.2

Financial Health

Updated on: 07/12/2023

DCF: Strong Buy

ROE: Neutral

ROA: Neutral

Debt to equity ratio: Buy

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

IART Discounted Cash Flow

Updated on: 07/12/2023

Discounted Cash Flow Value

Current Price

IART Revenues by Segment

Updated on: 07/12/2023

Codman Specialty Surgical
Tissue Technologies

Revenue from Contract with Customer, Excluding Assessed Tax

IART Revenues by Region

Updated on: 07/12/2023

Asia Pacific
Rest Of World

IART Notes Due

Updated on: 07/12/2023


There are no data to display

Integra LifeSciences Holdings (IART) Social Sentiments

Monitoring bullish and bearish sentiments towards Integra LifeSciences Holdings on Twitter and Stocktwits could help to forecast an upward or downward trend in Integra LifeSciences Holdings stock price.

No social results for IART

Integra LifeSciences Holdings' Stock Forecast: Potential for Long-term Growth Amidst Industry Recognition and Innovation

Integra LifeSciences Holdings (IART) is a leading global medical technology company that operates in the medical devices sector. They specialize in providing innovative products and services primarily focused on neurosurgery, orthopedics, and tissue technologies. With a proven track record of developing cutting-edge medical solutions that improve patient outcomes, Integra LifeSciences Holdings has become an industry heavyweight over the years. Their... Read more

Integra LifeSciences Holdings: A Promising Medical Device Stock Prediction Amidst Technological Advancement

As the world continues to advance technologically, the demand for medical devices is on a steady rise. The increasing need for innovative and advanced medical devices has led to the growth of the medical device stock market sector. It is one of the sectors that investors may consider investing in as there are various players in this field whose stocks... Read more